192 related articles for article (PubMed ID: 31981078)
41. Fertility-Sparing Options in Young Women with Cervical Cancer.
Tomao F; Corrado G; Peccatori FA; Boveri S; Preti EP; Colombo N; Landoni F
Curr Treat Options Oncol; 2016 Jan; 17(1):5. PubMed ID: 26810054
[TBL] [Abstract][Full Text] [Related]
42. Early cervical cancer.
Lu KH; Burke TW
Curr Treat Options Oncol; 2000 Jun; 1(2):147-55. PubMed ID: 12057052
[TBL] [Abstract][Full Text] [Related]
43. Promising predictive molecular biomarkers for cervical cancer (Review).
Lizano M; Carrillo-García A; De La Cruz-Hernández E; Castro-Muñoz LJ; Contreras-Paredes A
Int J Mol Med; 2024 Jun; 53(6):. PubMed ID: 38606495
[TBL] [Abstract][Full Text] [Related]
44. SEOM clinical guideline for treatment of kidney cancer (2019).
Lázaro M; Valderrama BP; Suárez C; de-Velasco G; Beato C; Chirivella I; González-Del-Alba A; Laínez N; Méndez-Vidal MJ; Arranz JA
Clin Transl Oncol; 2020 Feb; 22(2):256-269. PubMed ID: 31993962
[TBL] [Abstract][Full Text] [Related]
45. SEOM clinical guideline for the management of immune-related adverse events in patients treated with immune checkpoint inhibitors (2019).
Majem M; García-Martínez E; Martinez M; Muñoz-Couselo E; Rodriguez-Abreu D; Alvarez R; Arance A; Berrocal A; de la Cruz-Merino L; Lopez-Martin JA
Clin Transl Oncol; 2020 Feb; 22(2):213-222. PubMed ID: 31993963
[TBL] [Abstract][Full Text] [Related]
46. The impact of pre-therapy extraperitoneal surgical staging on the evaluation and treatment of patients with locally advanced cervical cancer.
Odunsi KO; Lele S; Ghamande S; Seago P; Driscoll DL
Eur J Gynaecol Oncol; 2001; 22(5):325-30. PubMed ID: 11766731
[TBL] [Abstract][Full Text] [Related]
47. Advanced cervical cancer.
Gibbons SK; Keys HM
Curr Treat Options Oncol; 2000 Jun; 1(2):157-60. PubMed ID: 12057053
[TBL] [Abstract][Full Text] [Related]
48. Emerging drugs for the treatment of cervical cancer.
Serrano-Olvera A; Cetina L; Coronel J; Dueñas-González A
Expert Opin Emerg Drugs; 2015 Jun; 20(2):165-82. PubMed ID: 25578210
[TBL] [Abstract][Full Text] [Related]
49. [Treatment protocol for cervical carcinoma].
Vujkov T; Zivaljević M; Novaković P; Erak M; Rajović J; Mandić A
Med Pregl; 2002; 55(3-4):105-8. PubMed ID: 12070925
[TBL] [Abstract][Full Text] [Related]
50. [Analysis of prognostic factors and therapeutic patterns of recurrent stage Ⅰb-Ⅱa cervical squamous carcinoma treated with radical hysterectomy].
Ou ZJ; Zhao D; An JS; Sun CY; Huang MN; Li B; Wu LY
Zhonghua Fu Chan Ke Za Zhi; 2019 Jun; 54(6):399-405. PubMed ID: 31262124
[No Abstract] [Full Text] [Related]
51. Radical hysterectomy followed by tailored postoperative therapy in the treatment of stage IB2 cervical cancer: feasibility and indications for adjuvant therapy.
Yessaian A; Magistris A; Burger RA; Monk BJ
Gynecol Oncol; 2004 Jul; 94(1):61-6. PubMed ID: 15262120
[TBL] [Abstract][Full Text] [Related]
52. Gynecologic Cancer InterGroup (GCIG) consensus review for cervical adenocarcinoma.
Fujiwara H; Yokota H; Monk B; Treilleux I; Devouassoux-Shisheboran M; Davis A; Kim JW; Mahner S; Stany M; Pignata S; Ray-Coquard I; Fujiwara K
Int J Gynecol Cancer; 2014 Nov; 24(9 Suppl 3):S96-101. PubMed ID: 25341589
[TBL] [Abstract][Full Text] [Related]
53. Distribution of platinum in the female genital tract and efficacy of radiotherapy combined with transcatheter arterial infusion of cisplatin for locally advanced stage IIIb carcinoma of the uterine cervix.
Nagai N; Kaneyasu Y; Komatsu M; Shiroyama Y; Oshita T; Watasaki S; Ito K
Oncol Rep; 2009 Mar; 21(3):585-91. PubMed ID: 19212615
[TBL] [Abstract][Full Text] [Related]
54. SEOM clinical guidelines in early-stage breast cancer 2015.
Garcia-Saenz JA; Bermejo B; Estevez LG; Palomo AG; Gonzalez-Farre X; Margeli M; Pernas S; Servitja S; Rodriguez CA; Ciruelos E
Clin Transl Oncol; 2015 Dec; 17(12):939-45. PubMed ID: 26497356
[TBL] [Abstract][Full Text] [Related]
55. Impact of nodal status and treatment strategy on overall survival in advanced stage cervical cancer.
Papathemelis T; Knobloch S; Gerken M; Scharl A; Anapolski M; Ignatov A; Inwald EC; Ortmann O; Scharl S; Klinkhammer-Schalke M
J Cancer Res Clin Oncol; 2019 May; 145(5):1369-1376. PubMed ID: 30887156
[TBL] [Abstract][Full Text] [Related]
56. Patients with locally advanced cervical cancer should not undergo routine pretreatment surgical staging.
Mota F; De Oliveira C
Eur J Gynaecol Oncol; 2006; 27(2):109-14. PubMed ID: 16620049
[TBL] [Abstract][Full Text] [Related]
57. The identification of patients at high risk for recurrent disease after treatment for early-stage cervical cancer.
Van Meir H; du Burck IJ; de Kam ML; Welters MJP; van der Burg SH; Trimbos JBMZ; de Kroon CD; van Poelgeest MIE
Eur J Gynaecol Oncol; 2017; 38(1):25-32. PubMed ID: 29767860
[TBL] [Abstract][Full Text] [Related]
58. SEOM clinical guidelines in metastatic breast cancer 2015.
Gavilá J; Lopez-Tarruella S; Saura C; Muñoz M; Oliveira M; De la Cruz-Merino L; Morales S; Alvarez I; Virizuela JA; Martin M
Clin Transl Oncol; 2015 Dec; 17(12):946-55. PubMed ID: 26683474
[TBL] [Abstract][Full Text] [Related]
59. Evaluation of the efficacy of prophylactic extended field irradiation in the concomitant chemoradiotherapy treatment of locally advanced cervical cancer, stage IIIB in the 2018 FIGO classification.
Meng Q; Liu X; Wang W; Hou X; Lian X; Sun S; Yan J; Liu Z; Miao Z; Hu K; Zhang F
Radiat Oncol; 2019 Dec; 14(1):228. PubMed ID: 31842919
[TBL] [Abstract][Full Text] [Related]
60. Critical review of neoadjuvant chemotherapy followed by surgery for locally advanced cervical cancer.
Colombo N; Peiretti M
Int J Gynecol Cancer; 2010 Oct; 20(11 Suppl 2):S47-8. PubMed ID: 21053527
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
